Why did EVEXIA.BO stock drop so much intraday?

The intraday drop was driven by heavy selling, high volume of **15,061,866.00**, weak small-cap sentiment, and no fresh positive catalysts. Leverage and mixed financial ratios raised investor caution, increasing supply pressure on the BSE.

What is Meyka AI’s outlook and forecast for EVEXIA.BO stock?

Meyka AI's forecast model projects **INR 1.75** monthly and **INR 1.40** quarterly for EVEXIA.BO stock. These imply upside of **+94.44%** and **+55.56%** from **INR 0.90**. Forecasts are model-based and not guarantees.

What are the main financial risks for EVEXIA.BO stock investors?

Key risks include high debt-to-equity (**2.16**), low operating cash flow, stretched receivables days (**334.79**), and thin margins. These raise solvency and liquidity concerns for EVEXIA.BO stock holders.

How should traders manage positions in EVEXIA.BO stock today?

Use tight stop-losses, limit position size, and wait for volume-backed moves above **INR 1.58**. Consider a bear-case target at **INR 0.60** and a recovery target near **INR 1.50** for planning risk-reward.

IN Stocks

EVEXIA.BO Evexia Lifecare BSE -23.08% intraday 18 Mar 2026: 94.44% upside

ByHuzaifa Zahoor March 18, 2026

The EVEXIA.BO stock slid sharply in intraday trade on 18 Mar 2026, closing at INR 0.90 after a -23.08% move on the BSE. Volume jumped to 15,061,866.00, nearly three times the average, amplifying the selloff. The drop follows weak trading ranges and pressure in small-cap energy names. We review drivers, valuation, technicals, and short-term forecasts to frame trading risks and the potential rebound.